These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Single-agent paclitaxel in the treatment of breast cancer: phase I and II development. Seidman AD Semin Oncol; 1999 Jun; 26(3 Suppl 8):14-20. PubMed ID: 10403469 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel in Breast Cancer. Perez EA Oncologist; 1998; 3(6):373-389. PubMed ID: 10388129 [TBL] [Abstract][Full Text] [Related]
5. [Weekly Taxol (Paclitaxel) administration in the second-line treatment of breast cancer]. Dank M Magy Onkol; 2002; 46(2):189-91. PubMed ID: 12202898 [TBL] [Abstract][Full Text] [Related]
6. [Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice]. Campone M; Fumoleau P Bull Cancer; 2002 Mar; 89(3):275-82. PubMed ID: 11940467 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer. Kim R; Osaki A; Toge T Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161 [TBL] [Abstract][Full Text] [Related]
8. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer]. Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628 [TBL] [Abstract][Full Text] [Related]
9. A simplified premedication schedule for 1-hour paclitaxel administration. Tsavaris N; Kosmas C; Vadiaka M J Support Oncol; 2005; 3(1):77-81. PubMed ID: 15724950 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan. Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212 [TBL] [Abstract][Full Text] [Related]
11. [Weekly paclitaxel therapy for metastatic breast cancer]. Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627 [TBL] [Abstract][Full Text] [Related]
12. Dose-intense paclitaxel: deja vu all over again? Takimoto CH; Rowinsky EK J Clin Oncol; 2003 Aug; 21(15):2810-4. PubMed ID: 12807932 [No Abstract] [Full Text] [Related]
13. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer]. Takahashi H; Takahashi M; Taguchi K; Sasaki F; Todo S Gan To Kagaku Ryoho; 2003 May; 30(5):653-9. PubMed ID: 12795097 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes. Kimura M; Sano M; Fujimori M; Nakagomi H; Negishi T; Yanagita Y; Sato N Anticancer Res; 2008; 28(2B):1239-44. PubMed ID: 18505061 [TBL] [Abstract][Full Text] [Related]
15. [Relation of dose intensity and efficacy, toxicity in paclitaxel as a single agent for advanced breast cancer]. Liu F; Jiang ZF; Song ST; Liu XQ; Wang T; Yan M; Zhang SH; Hao CF; Sun JZ; Shen G Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):56-8. PubMed ID: 15771802 [TBL] [Abstract][Full Text] [Related]
16. [Clinical study of weekly paclitaxel administration for metastatic breast cancer based on time to progression (TTP) and survival]. Emoto T; Yoshikawa K; Yoshioka Y; Nezu R; Fujikawa M; Fujii M; Maeda S; Naka Y; Komaki T Gan To Kagaku Ryoho; 2003 Jun; 30(6):817-22. PubMed ID: 12852349 [TBL] [Abstract][Full Text] [Related]
17. Weekly paclitaxel and 5-fluorouracil in pretreated patients with metastatic breast cancer: a phase I study. Cortesi E; Grifalchi F; Ramponi S; Padovani A; Mancuso A; Paoluzzi L; Ferrau F; Oliva A Anticancer Res; 2003; 23(2C):1961-6. PubMed ID: 12820487 [TBL] [Abstract][Full Text] [Related]
18. Weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small cell lung cancer: phase I study. Endo M; Takada Y; Obayashi K; Kotani Y; Satouchi M; Kado T; Sugimura K Radiat Med; 2005 Aug; 23(5):331-5. PubMed ID: 16342905 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer. Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388 [TBL] [Abstract][Full Text] [Related]
20. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. Winer EP; Berry DA; Woolf S; Duggan D; Kornblith A; Harris LN; Michaelson RA; Kirshner JA; Fleming GF; Perry MC; Graham ML; Sharp SA; Keresztes R; Henderson IC; Hudis C; Muss H; Norton L J Clin Oncol; 2004 Jun; 22(11):2061-8. PubMed ID: 15169793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]